CD4 and Kaposi's sarcoma: Among ART‐treated patients who had “normalized” their CD4 count (>500 cells/mm3), KS incidence was considerably lower (31/100,000 person‐years) but, again, still comparable to other important cancers (e.g., pancreas, stomach, and colon) as measured in resource‐rich regions 2.